Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tocilizumab 162mg/0.9ml inj pre-filled syringes
1001030W0AAADAD
|
Tocilizumab | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tocilizumab 80mg/4ml solution for infusion vials
1001030W0AAAAAA
|
Tocilizumab | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tofacitinib 10mg tablets
1001030ABAAACAC
|
Tofacitinib | Tofacitinib | Musculoskeletal and Joint Diseases | No data available |
|
Tofacitinib 11mg modified-release tablets
1001030ABAAADAD
|
Tofacitinib | Tofacitinib | Musculoskeletal and Joint Diseases | No data available |
|
Transvasin Heat spray
1003020T0BBABAF
|
Transvasin | Nicotinates | Musculoskeletal and Joint Diseases | No data available |
|
Traxam 3.17% foam
1003020M0BBABAB
|
Traxam | Felbinac | Musculoskeletal and Joint Diseases | No data available |
|
Triamcinolone hexacetonide 100mg/5ml inj vials
1001022Y0AAACAC
|
Triamcinolone hexacetonide | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | No data available |
|
Triamcinolone hexacetonide 20mg/1ml inj vials
1001022Y0AAABAB
|
Triamcinolone hexacetonide | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | No data available |
|
Turpentine liniment
1003020V0AAABAB
|
Generic embrocation | Turpentine oil | Musculoskeletal and Joint Diseases | No data available |
|
Tyenne 162mg/0.9ml inj pre-filled syringes
1001030W0BCAAAD
|
Tyenne | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tyenne 162mg/0.9ml solution for injection pre-filled pens
1001030W0BCABAE
|
Tyenne | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tyenne 200mg/10ml concentrate for inf vials
1001030W0BCADAB
|
Tyenne | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tyenne 400mg/20ml concentrate for inf vials
1001030W0BCACAC
|
Tyenne | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tyenne 80mg/4ml concentrate for solution for infusion vials
1001030W0BCAEAA
|
Tyenne | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Ultravana Period Pain Relief 250mg gastro-resistant tablets
1001010P0CBAAAH
|
Ultravana Period Pain Relief | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Upadacitinib 45mg modified-release tablets
1001030AEAAACAC
|
Upadacitinib | Upadacitinib | Musculoskeletal and Joint Diseases | No data available |
|
Uricto 300mg tablets
1001040C0BLABAB
|
Uricto | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Valdecoxib 10mg tablets
1001010ALAAAAAA
|
Valdecoxib | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Valdecoxib 20mg tablets
1001010ALAAABAB
|
Valdecoxib | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Valdecoxib 40mg tablets
1001010ALAAACAC
|
Valdecoxib | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Valdic 100 Retard tablets
1001010C0CHAAAF
|
Valdic | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Valdic 75 Retard tablets
1001010C0CHABAL
|
Valdic | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Valket 200 Retard capsules
1001010L0BNAAAJ
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Valupak Vegetarian Glucosamine hydrochloride 500mg tablets
1001050A0BNAAAJ
|
Valupak (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Vegetarian Glucosamine hydrochloride 750mg tablets
1001050A0BXAAAB
|
BR Pharm (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.